These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 459788)

  • 1. [A controlled experience with a thermostabile measles vaccine in Cameroon (author's transl)].
    Heymann DL; Nakano J; Durand B
    Med Trop (Mars); 1979; 39(1):67-70. PubMed ID: 459788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age for measles immunization seroconversion after measles vaccination at 6-8 months of age--a randomized controlled trial.
    Deivanayagam N; Ramamurthy N; Krishnamurthy PV; Shankar VJ; Ashok TP; Nedunchelian K; Mala N; Ahmed SS
    Indian Pediatr; 1990 Nov; 27(11):1171-6. PubMed ID: 2081639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Field trial of a heat-stable measles vaccine in Papua New Guinea.
    Climie A; André FE
    J Trop Med Hyg; 1984 Dec; 87(6):249-55. PubMed ID: 6534989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is the first dental eruption a good criterion to fix the time of anti-measles immunization? (author's transl)].
    Perier H; Husser JA
    Med Trop (Mars); 1979; 39(5):559-63. PubMed ID: 530041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous administration of live attenuated measles vaccine with DTP vaccine.
    McBean AM; Gateff C; Manclark CR; Foster SO
    Pediatrics; 1978 Sep; 62(3):288-93. PubMed ID: 704197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measles vaccination with split vaccines and living vaccines (author's transl)].
    Stehr K; Enders-Ruckle G; Spiess H
    MMW Munch Med Wochenschr; 1975 Jul; 117(27):1159-64. PubMed ID: 808710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of mass measles campaigns among children less than 5 years old in Uganda.
    Nanyunja M; Lewis RF; Makumbi I; Seruyange R; Kabwongera E; Mugyenyi P; Talisuna A
    J Infect Dis; 2003 May; 187 Suppl 1():S63-8. PubMed ID: 12721893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two doses of measles vaccine: are some states in India ready for it?
    John S; Sanghi S; Prasad S; Bose A; George K
    J Trop Pediatr; 2009 Aug; 55(4):253-6. PubMed ID: 18799515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles and measles vaccine efficacy in a remote island population.
    McIntyre RC; Preblud SR; Polloi A; Korean M
    Bull World Health Organ; 1982; 60(5):767-75. PubMed ID: 6983927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of urban measles mass campaigns for children aged 9-59 months in Mali.
    Kertesz DA; Touré K; Berthé A; Konaté Y; Bougoudogo F
    J Infect Dis; 2003 May; 187 Suppl 1():S69-73. PubMed ID: 12721894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles vaccine efficacy in children previously vaccinated at 12 months of age.
    Marks JS; Halpin TJ; Orenstein WA
    Pediatrics; 1978 Dec; 62(6):955-60. PubMed ID: 733423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA; Harry TO
    Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What is wrong with the measles vaccine in Mexico? Study of an epidemic outbrake of measles].
    Sánchez Y; Alvarez PF; Saldaña E; Salomón A; Ruiz-Gómez J; Muñoz O
    Bol Med Hosp Infant Mex; 1977; 34(2):291-7. PubMed ID: 843401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Simultaneous vaccination with BCG and measles vaccine: results of a controlled trial].
    Dutertre J; Labusquiere R; Boisson P; Gateff C; Barme P; Taylor M
    Rev Epidemiol Med Soc Sante Publique; 1975; 23(7-8):397-415. PubMed ID: 1084093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial of Edmonston-Zagreb measles vaccine in infants aged under nine months.
    Pongrithsukda V; Gluck R; Suwatanapongched S; Kaewmalung P; Muyakul J
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):347-50. PubMed ID: 1818384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella].
    Just M; Berger R; Glück R; Wegmann A
    Schweiz Med Wochenschr; 1985 Nov; 115(48):1727-30. PubMed ID: 4081704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroconversion rates and measles antibody titers induced by measles vaccination in Latin American children six to 12 months of age.
    Rev Infect Dis; 1983; 5(3):596-605. PubMed ID: 6879022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.